229 related articles for article (PubMed ID: 12547500)
1. Determinant spreading and tumor responses after peptide-based cancer immunotherapy.
Ribas A; Timmerman JM; Butterfield LH; Economou JS
Trends Immunol; 2003 Feb; 24(2):58-61. PubMed ID: 12547500
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-based vaccines and therapies for cancer.
Tatsumi T; Storkus WJ
Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
[TBL] [Abstract][Full Text] [Related]
3. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.
Nishida S; Sugiyama H
Methods Mol Biol; 2016; 1467():221-32. PubMed ID: 27417973
[TBL] [Abstract][Full Text] [Related]
5. [Dendritic cell-based cancer immunotherapy].
Aruga A
Nihon Rinsho; 2010 Jun; 68(6):1107-10. PubMed ID: 20535963
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell gene therapy.
Onaitis M; Kalady MF; Pruitt S; Tyler DS
Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
8. Current developments of immunotherapy in the clinic.
Antonia S; Mulé JJ; Weber JS
Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
[TBL] [Abstract][Full Text] [Related]
9. Current status and future applications of cellular therapies for cancer.
Copier J; Bodman-Smith M; Dalgleish A
Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in tumor immunology and immunotherapy.
Turtle CJ; Hart DN
Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
[TBL] [Abstract][Full Text] [Related]
11. WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.
Oka Y; Tsuboi A; Fujiki F; Li Z; Nakajima H; Hosen N; Shirakata T; Nishida S; Oji Y; Kawase I; Sugiyama H
Anticancer Agents Med Chem; 2009 Sep; 9(7):787-97. PubMed ID: 19538172
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?
Parmiani G; Castelli C; Dalerba P; Mortarini R; Rivoltini L; Marincola FM; Anichini A
J Natl Cancer Inst; 2002 Jun; 94(11):805-18. PubMed ID: 12048268
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy: moving beyond current vaccines.
Rosenberg SA; Yang JC; Restifo NP
Nat Med; 2004 Sep; 10(9):909-15. PubMed ID: 15340416
[TBL] [Abstract][Full Text] [Related]
14. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
15. Cancer vaccines: dream, reality, or nightmare?
Biagi E; Rousseau RF; Yvon E; Vigouroux S; Dotti G; Brenner MK
Clin Exp Med; 2002 Nov; 2(3):109-18. PubMed ID: 12463196
[No Abstract] [Full Text] [Related]
16. The present status and future prospects of peptide-based cancer vaccines.
Hirayama M; Nishimura Y
Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading.
Ranieri E; Kierstead LS; Zarour H; Kirkwood JM; Lotze MT; Whiteside T; Storkus WJ
Immunol Invest; 2000 May; 29(2):121-5. PubMed ID: 10854179
[No Abstract] [Full Text] [Related]
18. Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition.
Correa I; Plunkett T
Breast Cancer Res; 2001; 3(6):399-403. PubMed ID: 11737893
[TBL] [Abstract][Full Text] [Related]
19. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.
Markiewicz MA; Kast WM
Cancer Invest; 2004; 22(3):417-34. PubMed ID: 15493363
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with dendritic cells for cancer.
Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
